-
Je něco špatně v tomto záznamu ?
The Effects of the Coating and Aging of Biodegradable Polylactic Acid Membranes on In Vitro Primary Human Retinal Pigment Epithelium Cells
G. Faura, H. Studenovska, D. Sekac, Z. Ellederova, G. Petrovski, L. Eide
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
TO01000107
Norwegian Research Council
801133
European Union
No. CZ.02.01.01/00/22_008/0004562
European Regional Development Fund
NLK
Directory of Open Access Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
ProQuest Central
od 2013-01-01
Open Access Digital Library
od 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2013
- Publikační typ
- časopisecké články MeSH
Age-related macular degeneration (AMD) is the most frequent cause of blindness in developed countries. The replacement of dysfunctional human retinal pigment epithelium (hRPE) cells by the transplantation of in vitro-cultivated hRPE cells to the affected area emerges as a feasible strategy for regenerative therapy. Synthetic biomimetic membranes arise as powerful hRPE cell carriers, but as biodegradability is a requirement, it also poses a challenge due to its limited durability. hRPE cells exhibit several characteristics that putatively respond to the type of membrane carrier, and they can be used as biomarkers to evaluate and further optimize such membranes. Here, we analyze the pigmentation, transepithelial resistance, genome integrity, and maturation markers of hRPE cells plated on commercial polycarbonate (PC) versus in-house electrospun polylactide-based (PLA) membranes, both enabling separate apical/basolateral compartments. Our results show that PLA is superior to PC-based membranes for the cultivation of hRPEs, and the BEST1/RPE65 maturation markers emerge as the best biomarkers for addressing the quality of hRPE cultivated in vitro. The stability of the cultures was observed to be affected by PLA aging, which is an effect that could be partially palliated by the coating of the PLA membranes.
CIDETEC Basque Research and Technology Alliance 20014 Donostia San Sebastián Spain
Department of Cell Biology Faculty of Science Charles University 128 00 Prague Czech Republic
Department of Medical Biochemistry Oslo University Hospital 0424 Oslo Norway
Norwegian Center for Stem Cell Research Oslo University Hospital 0424 Oslo Norway
UKLO Network University St Kliment Ohridski 7000 Bitola North Macedonia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24012913
- 003
- CZ-PrNML
- 005
- 20240726151441.0
- 007
- ta
- 008
- 240723s2024 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/biomedicines12050966 $2 doi
- 035 __
- $a (PubMed)38790928
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Faura, Georgina $u Department of Medical Biochemistry, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0372 Oslo, Norway $u CIDETEC, Basque Research and Technology Alliance (BRTA), 20014 Donostia-San Sebastián, Spain $1 https://orcid.org/000000015420471X
- 245 14
- $a The Effects of the Coating and Aging of Biodegradable Polylactic Acid Membranes on In Vitro Primary Human Retinal Pigment Epithelium Cells / $c G. Faura, H. Studenovska, D. Sekac, Z. Ellederova, G. Petrovski, L. Eide
- 520 9_
- $a Age-related macular degeneration (AMD) is the most frequent cause of blindness in developed countries. The replacement of dysfunctional human retinal pigment epithelium (hRPE) cells by the transplantation of in vitro-cultivated hRPE cells to the affected area emerges as a feasible strategy for regenerative therapy. Synthetic biomimetic membranes arise as powerful hRPE cell carriers, but as biodegradability is a requirement, it also poses a challenge due to its limited durability. hRPE cells exhibit several characteristics that putatively respond to the type of membrane carrier, and they can be used as biomarkers to evaluate and further optimize such membranes. Here, we analyze the pigmentation, transepithelial resistance, genome integrity, and maturation markers of hRPE cells plated on commercial polycarbonate (PC) versus in-house electrospun polylactide-based (PLA) membranes, both enabling separate apical/basolateral compartments. Our results show that PLA is superior to PC-based membranes for the cultivation of hRPEs, and the BEST1/RPE65 maturation markers emerge as the best biomarkers for addressing the quality of hRPE cultivated in vitro. The stability of the cultures was observed to be affected by PLA aging, which is an effect that could be partially palliated by the coating of the PLA membranes.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Studenovska, Hana $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, 162 00 Prague, Czech Republic $1 https://orcid.org/0000000179171790
- 700 1_
- $a Sekac, David $u Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, 277 21 Libechov, Czech Republic $u Department of Cell Biology, Faculty of Science, Charles University, 128 00 Prague, Czech Republic $1 https://orcid.org/0009000565460221
- 700 1_
- $a Ellederova, Zdenka $u Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, 277 21 Libechov, Czech Republic
- 700 1_
- $a Petrovski, Goran $u Center for Eye Research and Innovative Diagnostics, Department of Ophthalmology, Oslo University Hospital and Institute for Clinical Medicine, University of Oslo, 0424 Oslo, Norway $u Norwegian Center for Stem Cell Research, Oslo University Hospital, 0424 Oslo, Norway $u Department of Ophthalmology, University Hospital Centre, University of Split School of Medicine, 21000 Split, Croatia $u UKLO Network, University St. Kliment Ohridski, 7000 Bitola, North Macedonia $1 https://orcid.org/0000000329059252
- 700 1_
- $a Eide, Lars $u Department of Medical Biochemistry, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0372 Oslo, Norway $u Department of Medical Biochemistry, Oslo University Hospital, 0424 Oslo, Norway
- 773 0_
- $w MED00205373 $t Biomedicines $x 2227-9059 $g Roč. 12, č. 5 (2024)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38790928 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240723 $b ABA008
- 991 __
- $a 20240726151434 $b ABA008
- 999 __
- $a ok $b bmc $g 2125520 $s 1224776
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 12 $c 5 $e 20240426 $i 2227-9059 $m Biomedicines $n Biomedicines $x MED00205373
- GRA __
- $a TO01000107 $p Norwegian Research Council
- GRA __
- $a 801133 $p European Union
- GRA __
- $a No. CZ.02.01.01/00/22_008/0004562 $p European Regional Development Fund
- LZP __
- $a Pubmed-20240723